Fractions of chemically oversulphated galactosaminoglycan sulphates inhibit three enveloped viruses: Human immunodeficiency virus type 1, herpes simplex virus type 1 and human cytomegalovirus

Antiviral Chemistry and Chemotherapy

Volumn 10, Issue 1, 1999, Pages 33-38

  Di Caro, A ^a   Perola, E ^b   Bartolini, B ^b   Marzano, M ^b   Liverani, L ^c   Mascellani, G ^c   Benedetto, A ^a   Cellai, L ^b  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b CNR   (Italy)

^c Opocrin Research Laboratories   (Italy)

Author keywords

AIDS; HCMV; HIV; HSV; Oversulphated chondroitins; Oversulphated dermatans

Indexed keywords

ANTIVIRUS AGENT; CHONDROITIN; DERMATAN SULFATE; GALACTOSAMINOGLYCAN; SULFATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SULFATION; HERPES SIMPLEX VIRUS 1; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR WEIGHT; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0033022511     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029901000104     Document Type: Article

References (21)

1. Baba M, Nakajima M, Schols D, Pauwels R, Balzarini J & De Clercq E (1988a) Pentosan polysulfate, a sulfated oligosaccaride, is a potent and selective anti-HIV agent in vitro. Antiviral Research 9:335-343.
2. Baba M, Pauwels R, Balzarini J, Arnout J, Desmyter J * De Clercq E (1988b) Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunedeficiency virus in vitro. Proceedings of the National Academy of Sciences, USA 85:6132-6136.
3. Bartolucci C, Cellai L, Iannelli MA, Lamba D, Liverani L, Mascellani G * Perola E (1995) Inhibition of human leukocyte elastase by chemically and naturally oversulphated galactosaminoglycans. Carbohydrate Research 276:401-408.
4. 1H-n.m.r. investigation of naturally occurring and chemically oversulphated dermatan sulphates. Biochemical Journal 267:625-630.
5. Gerna G, Revello MG, Percivalle E, Zavattoni M, Parea M & Battaglia M (1990) Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. Journal of Clinical Microbiology 28:2681-2688.
6. Harrop HA & Rider CC (1998) Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4. Glycobiology 8:131-137.
7. Ito M, Baba M, Sato A, Pauwels R, De Clercq E & Shigeta S (1987) Inhibitory effect of dextran sulfate and heparin on the replication of human immunedeficency virus (HlV) in vitro. Antiviral Research 7:361-367.
8. Jurkiewicz E, Panse P, Jentsh K-D, Hartmann H * Hunsmann G (1989) In vitro anti-HIV activity of chondroitin polysulphate. AIDS 3:423-427.
9. Leydet A, El Hachemi H, Boyer B, Lawety G, Roque JP, Schols D, Snoeck R, Andrei G, Ikeda S, Neyts J, Reymen D, Este J, Witvrouw M * De Clercq E (1996) Polyanion inhibitors of human immunedeficiency virus and the other viruses. Part 2. Polymerised anionic surfactans derived from aminoacids and dipeptides. Journal of Medical Chemistry 39:1626-1634.
10. Mascellani G, Liverani L, Prete A, Bergonzini GL, Bianchini P, Silvestro L, Torri G, Guerrmi M * Casu B (1995) Active sites of derrnatan sulphate for heparin cofactor II. Isolation of a nonasaccharide fragment containing four disaccharide sequences [α-L-iduronic acid 2-O-sulfate (1, 3)-β-D-N-acetylgalactosamine 4-sulfate]. Journal of Carbohydrate Chemistry 14:1165-1177.
11. Nagasawa K, Uchiyama H & Wajima N (1986) Chemical sulfation of preparations of chondroitin 4- and 6-sulfate, and dermatan sulfate. Preparation of chondroitin sulfate E-like materials from chondroitin 4-sulfate. Carbohydrate Research 158:183-190.
12. Naggi A, Torri G, Angiuli P, Casu B, Mantovani M, Pescador R & Porta R (1989) Sulfamino-galactosaminoglycans, a new class of semi-synthetic polysaccharides. Preparation, characterisation and lipase-releasing properties. In Biomedical and Biotechnological Advances in Industrial Polysaccharides, pp. 101-108. Edited by V Crescenzi, ICM Dea, S Paoletti, SS Stivala & IW Sutherland. New York: Gordon & Breach.
13. Nahmias AJ & Kibrick S (1964) Inhibitory effect of heparin on herpes simplex virus. Journal of Bacteriolgy 87:1061-1066.
14. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J & De Clercq E (1988) Rapid and automatic tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. Journal of Virological Methods 20:309-321.
15. Schols D, De Clercq E, Balzarini J, Baba M, Witvrouw M, Hosoya M, Andrei G, Snoeck R, Neyts J, Pauwels R, Nagy M, GyorgyiEdelényi S, Machovich R, Horvath I, Low M & Gorog S (1990) Sulfated polymers are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, respiratory syncitial virus, and togaarena- and retroviruses. Antiviral Chemistry and Chemotherapy 1:223-240.
16. Thomson JM & Poller L (1985). The activated thromboplastin time. In Blood Coagulation andHemostasis, pp 301-313. Edited by JM Thomson. Edinburgh: Churchill Livingstone.
17. Venkataraman G, Sasisekharan V, Cooney CL, Langer R & Sasisekharan R (1994) A stereochemical approach to pyranose ring flexibility: its implications for the conformation of dermatan sulfate. Proceedings of the National Academy of Sciences, USA 91:6171-6175.
18. Volpi N, Mascellani G, Bianchini P & Liverani L (1992) Analytical techniques for studying structures of dermatan sulfate and low molecular mass dermatan sulfate. Farmaco 47:841-853.
19. Whistler PL & Spencer WW (1964) Sulfation. Triethylamine-sulfur trioxide complex. Methods in Carbohydrate Chemistry 4:297-298.
20. Witvrouw M & De Clercq E (1997) Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. General Pharmacology 29:497-511.
21. Wolfrom ML, Shen TM & Summers CG (1953) Sulfated nitrogenous polysaccharides and their anticoagulant activity. Journal of the American Chemical Society 75:1519.